Latest market price
25.70
-1.10-4.10%
OverviewShort InterestFilings
NRIXQT90Nurix Therapeutics, Inc.·NASDAQ
25.70-4.10%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 15, 20264Statement of changes in beneficial ownership
Oct 14, 20264Statement of changes in beneficial ownership
Oct 13, 202610-QQuarterly report
Oct 13, 20268-KCurrent report
Oct 02, 20264Statement of changes in beneficial ownership
Sep 23, 2026SC 13GBeneficial ownership statement (passive)
Sep 02, 20264Statement of changes in beneficial ownership
Sep 01, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 05, 20264Statement of changes in beneficial ownership
Aug 05, 20264Statement of changes in beneficial ownership
Aug 04, 20264Statement of changes in beneficial ownership
Aug 03, 20264Statement of changes in beneficial ownership
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 30, 20264Statement of changes in beneficial ownership
Jul 30, 20264Statement of changes in beneficial ownership
Jul 30, 20264Statement of changes in beneficial ownership
Jul 09, 202610-QQuarterly report
Jul 09, 20268-KCurrent report
Jul 02, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
#1 / 25 of 428
Page
▼
/ 18